Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

BACKGROUND: An infection with high-risk human papillomavirus (HPV) is the obligatory aetiological factor for the development of cervical cancer. In Switzerland, the prevention strategy for cervical cancer is based on primary prevention via HPV vaccination and secondary prevention with an opportunist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kind, André B., Pavelyev, Andrew, Kothari, Smita, El Mouaddin, Nadia, Schmidt, Aurélie, Morais, Edith, Guggisberg, Patrik, Lienert, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216682/
https://www.ncbi.nlm.nih.gov/pubmed/32398057
http://dx.doi.org/10.1186/s12889-020-08840-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216682/
https://www.ncbi.nlm.nih.gov/pubmed/32398057
http://dx.doi.org/10.1186/s12889-020-08840-0

Ejemplares similares